113 related articles for article (PubMed ID: 33462777)
1. Evaluation of the Risk of Inflammatory Bowel Disease after the HPV Vaccination in Primary Care in Spain: A Time-Varying Cohort Analysis of Around 390,000 Girls.
Martín-Merino E; Castillo-Cano B; Martín-Pérez M; Llorente-García A; Montero-Corominas D
Drug Saf; 2021 Apr; 44(4):455-466. PubMed ID: 33462777
[TBL] [Abstract][Full Text] [Related]
2. Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain.
Martín-Merino E; Castillo-Cano B; Martín-Perez M; Llorente-García A; Montero-Corominas D
Vaccine; 2021 Jul; 39(31):4306-4313. PubMed ID: 34175126
[TBL] [Abstract][Full Text] [Related]
3. Assessment of thyroiditis risk associated with HPV vaccination among girls aged 9-18 years: A time-varying cohort study.
Castillo-Cano B; Martín-Pérez M; Llorente-García A; Montero-Corominas D; Comas-Cufí M; Martín-Merino E
Vaccine; 2022 Aug; 40(33):4816-4826. PubMed ID: 35792023
[TBL] [Abstract][Full Text] [Related]
4. The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 10 Years After Approval.
Martín-Merino E; Llorente-García A; Castillo Cano B; Montero Corominas D; Huerta-Álvarez C
Pharmaceut Med; 2019 Dec; 33(6):519-530. PubMed ID: 31933243
[TBL] [Abstract][Full Text] [Related]
5. The recording of human papillomavirus (HPV) vaccination in BIFAP primary care database: A validation study.
Martín-Merino E; Llorente-García A; Montero-Corominas D; Huerta C
Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):201-208. PubMed ID: 30488510
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the risk of autoimmune thyroiditis, Guillain-Barré syndrome, and inflammatory bowel disease following vaccination with AS04-adjuvanted human papillomavirus 16/18 vaccine.
Rosillon D; Willame C; Tavares Da Silva F; Guignard A; Caterina S; Welby S; Struyf F
Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1159-1167. PubMed ID: 32583515
[TBL] [Abstract][Full Text] [Related]
7. Association between administration or recommendation of the human papillomavirus vaccine and primary care physicians' knowledge about vaccination during proactive recommendation suspension: a nationwide cross-sectional study in Japan.
Sakanishi Y; Takeuchi J; Suganaga R; Nakayama K; Nishioka Y; Chiba H; Kishi T; Machino A; Mastumura M; Okada T; Suzuki T
BMJ Open; 2023 Nov; 13(11):e074305. PubMed ID: 37993154
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccination and risk of autoimmune diseases: A large cohort study of over 2million young girls in France.
Miranda S; Chaignot C; Collin C; Dray-Spira R; Weill A; Zureik M
Vaccine; 2017 Aug; 35(36):4761-4768. PubMed ID: 28750853
[TBL] [Abstract][Full Text] [Related]
9. The status of human papillomavirus vaccination recommendation, funding, and coverage in WHO Europe countries (2018-2019).
Bonanni P; Faivre P; Lopalco PL; Joura EA; Bergroth T; Varga S; Gemayel N; Drury R
Expert Rev Vaccines; 2020 Nov; 19(11):1073-1083. PubMed ID: 33267673
[No Abstract] [Full Text] [Related]
10. Reaching 80% human papillomavirus vaccination prevalence by 2026: How many adolescents need to be vaccinated and what are their characteristics?
Fedewa SA; Preiss AJ; Fisher-Borne M; Goding Sauer A; Jemal A; Saslow D
Cancer; 2018 Dec; 124(24):4720-4730. PubMed ID: 30257056
[TBL] [Abstract][Full Text] [Related]
11. No evidence found for an increased risk of long-term fatigue following human papillomavirus vaccination of adolescent girls.
Schurink-Van't Klooster TM; Kemmeren JM; van der Maas NAT; van de Putte EM; Ter Wolbeek M; Nijhof SL; Vanrolleghem AM; van Vliet JA; Sturkenboom M; de Melker HE
Vaccine; 2018 Oct; 36(45):6796-6802. PubMed ID: 30262246
[TBL] [Abstract][Full Text] [Related]
12. The recording and prevalence of Inflammatory bowel disease in girls' primary care medical Spanish records.
Martín-Merino E; Martín-Pérez M; Castillo-Cano B; Montero-Corominas D
Pharmacoepidemiol Drug Saf; 2020 Nov; 29(11):1440-1449. PubMed ID: 32885513
[TBL] [Abstract][Full Text] [Related]
13. Association Between Human Papillomavirus Vaccination and Primary Ovarian Insufficiency in a Nationwide Cohort.
Hviid A; Myrup Thiesson E
JAMA Netw Open; 2021 Aug; 4(8):e2120391. PubMed ID: 34436612
[TBL] [Abstract][Full Text] [Related]
14. Quadrivalent HPV vaccination and risk of multiple sclerosis and other demyelinating diseases of the central nervous system.
Scheller NM; Svanström H; Pasternak B; Arnheim-Dahlström L; Sundström K; Fink K; Hviid A
JAMA; 2015 Jan; 313(1):54-61. PubMed ID: 25562266
[TBL] [Abstract][Full Text] [Related]
15. Association between human papillomavirus vaccination and serious adverse events in South Korean adolescent girls: nationwide cohort study.
Yoon D; Lee JH; Lee H; Shin JY
BMJ; 2021 Jan; 372():m4931. PubMed ID: 33514507
[TBL] [Abstract][Full Text] [Related]
16. RETRACTED ARTICLE: The Longitudinal Incidence of Human Papillomavirus Vaccination in Spanish Primary Care in the First 6 Years After Approval.
Martín-Merino E; Llorente-García A; Montero Corominas D; Huerta-Álvarez C
Pharmaceut Med; 2019 Apr; 33(2):135-144. PubMed ID: 31933248
[TBL] [Abstract][Full Text] [Related]
17. What Impacts HPV Vaccination Recommendations? An Exploration of Medical Residents' Knowledge, Training, Barriers, and Practices.
Hansen K; Ward M; Avashia S; Duc J; Spielberg F
Fam Med; 2020 Nov; 52(10):745-751. PubMed ID: 33151536
[TBL] [Abstract][Full Text] [Related]
18. Does intention to recommend HPV vaccines impact HPV vaccination rates?
Feemster KA; Middleton M; Fiks AG; Winters S; Kinsman SB; Kahn JA
Hum Vaccin Immunother; 2014; 10(9):2519-26. PubMed ID: 25483470
[TBL] [Abstract][Full Text] [Related]
19. Coverage of human papillomavirus vaccination during the first year of its introduction in Spain.
Limia A; Pachón I
Euro Surveill; 2011 May; 16(21):. PubMed ID: 21632017
[TBL] [Abstract][Full Text] [Related]
20. The association of adverse events with bivalent human papilloma virus vaccination: A nationwide register-based cohort study in Finland.
Skufca J; Ollgren J; Artama M; Ruokokoski E; Nohynek H; Palmu AA
Vaccine; 2018 Sep; 36(39):5926-5933. PubMed ID: 30115524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
